New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Cardio Diagnostics Holdings, Inc. (CDIO) vs Lantern Pharma Inc. (LTRN)
- Cardio Diagnostics Holdings, Inc. CDIO 1.65 −2.37%
- Lantern Pharma Inc. LTRN 0.28 −15.15%
Cardio Diagnostics Holdings, Inc. and Lantern Pharma Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Lantern Pharma Inc. are of similar size ($4.9M and $4.9M). Lantern Pharma Inc. has the higher net margin (0.00% vs −42,401.3%) and the higher return on invested capital (0.00% vs −228.0%). Across the 13 metrics below, Cardio Diagnostics Holdings, Inc. leads on 8 and Lantern Pharma Inc. on 5.
Valuation
Profitability
| Metric | CDIO | LTRN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 70.18% |
| Operating margin | (42,328.76%) | 0.00% | 0.00% |
| Net margin | (42,401.31%) | 0.00% | 0.00% |
| Free cash flow margin | (37,804.58%) | 0.00% | 0.00% |
| Return on equity | (93.55%) | (250.59%) | (51.58%) |
| Return on assets | (87.24%) | (124.41%) | (45.91%) |
| Return on invested capital | (227.99%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack